Vasta Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 88.40 K
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -9.20%
- Profit Growth -45.97%
- Ebitda 13.01%
- Net Worth -26.30%
- Total Assets -24.98%
About Vasta Biotech
Vasta Biotech Private Limited (VBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 March 2005 and has a history of 19 years and 11 months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 88.40 K , as per Ministry of Corporate Affairs (MCA) records.
Subha Srikanth and Singanallur Srikanth serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999TN2005PTC055681
- Company No.
055681
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Vasta Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Singanallur Srikanth  | Managing Director | 16-Mar-2005 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subha Srikanth | Director | 16-Mar-2005 | Current |
Financial Performance of Vasta Biotech.
Vasta Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.2% decrease. The company also saw a substantial fall in profitability, with a 45.97% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vasta Biotech?
Unlock access to Vasta Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Porto Novo Maritime LimitedSinganallur Srikanth is a mutual person
Diana Shutters Private LimitedSubha Srikanth and Singanallur Srikanth are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vasta Biotech?
Unlock and access historical data on people associated with Vasta Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vasta Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vasta Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.